![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||
Copyright © 2008 by The Endocrine Society Deletion of Dicer in Somatic Cells of the Female Reproductive Tract Causes Sterility Departments of Pathology (A.K.N., C.A.-V., L.M., R.C., D.Y.H., J.E.A., P.H.G., M.M.M.), Molecular and Human Genetics (A.K.N., M.M.M.), and Molecular and Cellular Biology (H.L.F., F.J.D., M.M.M.), Human Genome Sequencing Center (P.H.G.), and Program in Developmental Biology (F.J.D., M.M.M.), Baylor College of Medicine, Houston, Texas 77030; and Departments of Physics (H.Z.) and Biology and Biochemistry (P.H.G.), University of Houston, Houston, Texas 77004 aA.K.N. and C.A.-V. contributed equally to this work. Address all correspondence and requests for reprints to: Martin M. Matzuk, M.D., Ph.D., Stuart A. Wallace Chair and Professor, Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Room S217, Houston, Texas 77030. E-mail: mmatzuk/at/bcm.edu. Received April 28, 2008; Accepted July 25, 2008. This article has been cited by other articles in PMC.Abstract Dicer is an evolutionarily conserved ribonuclease III that is necessary for microRNA (miRNA) processing and the synthesis of small interfering RNAs from long double-stranded RNA. Although it has been shown that Dicer plays important roles in the mammalian germline and early embryogenesis, the functions of Dicer-dependent pathways in the somatic cells of the female reproductive tract are unknown. Using a transgenic line in which Cre recombinase is driven by the anti-Müllerian hormone receptor type 2 promoter, we conditionally inactivated Dicer1 in the mesenchyme of the developing Müllerian ducts and postnatally in ovarian granulosa cells and mesenchyme-derived cells of the oviducts and uterus. Deletion of Dicer in these cell types results in female sterility and multiple reproductive defects including decreased ovulation rates, compromised oocyte and embryo integrity, prominent bilateral paratubal (oviductal) cysts, and shorter uterine horns. The paratubal cysts act as a reservoir for spermatozoa and oocytes and prevent embryos from transiting the oviductal isthmus and passing the uterotubal junction to enter the uterus for implantation. Deep sequencing of small RNAs in oviduct revealed down-regulation of specific miRNAs in Dicer conditional knockout females compared with wild type. The majority of these differentially expressed miRNAs are predicted to regulate genes important for Müllerian duct differentiation and mesenchyme-derived structures, and several of these putative target genes were significantly up-regulated upon conditional deletion of Dicer1. Thus, our findings reveal diverse and critical roles for Dicer and its miRNA products in the development and function of the female reproductive tract. MICRORNAS (miRNAS) ARE approximately 22-nucleotide, single-stranded, noncoding RNAs that are critical elements of gene regulatory networks in plants and animals (1). These small RNAs direct the translational repression or degradation of complementary target mRNAs, potentially functioning as molecular rheostats to fine tune cellular protein production (2). miRNAs are essential for mammalian development through their regulation of fundamental cellular processes, namely growth, differentiation, and apoptosis. They are synthesized as long primary transcripts that are cleaved by a ribonuclease (RNase) III, Drosha, to yield an approximately 70-nucleotide stem loop precursor miRNA (pre-miRNA). The pre-miRNA is exported to the cytoplasm and subsequently cleaved by a second RNase III, Dicer (encoded by Dicer1), to excise the approximately 22-nucleotide miRNA:miRNAa duplex, one strand of which is preferentially incorporated into the RNA-induced silencing complex. Unlike miRNAs, small interfering (siRNAs) are derived from larger double-stranded RNAs that are processed by Dicer. Whereas siRNAs function in mRNA degradation by forming siRNA:mRNA duplexes, miRNAs often bind to the 3′-untranslated region of mRNAs in a perfect or imperfect match to regulate mRNA cleavage or translational repression, respectively (reviewed in Refs. 3 and 4). The role of miRNAs, siRNAs, and the processing enzyme Dicer in the regulation of gene expression has been shown to be conserved from yeast to mammals (5,6,7,8,9). For instance, recent reports have shown that miRNAs regulate the expression of a variety of steroid hormone receptors including human estrogen receptor α (10), the ecdysone receptor in fruit flies (11), and nuclear hormone receptors 23 and 25 in worms (12). In mice, Dicer null and hypomorphic mutations result in postimplantation embryonic lethality [embryonic d 7.5 (E7.5) and E12.5-E14.5, respectively (9,13)]. Mutations in both Dicer and Dgcr8, an essential cofactor for Drosha, indicate that miRNAs are essential for embryonic stem cell differentiation (14,15). Loss of embryonic stem cells has also been shown to occur in the absence of Dicer (9), likely due to the inability of Dicer null stem cells to generate miRNAs, as demonstrated by high-throughput small RNA sequencing (16). Due to the embryonic lethality demonstrated by Dicer null and hypomorphic mice, the study of mammalian Dicer and its miRNA/siRNA products in late embryogenesis and postnatal development requires a conditional knockout (cKO) approach. Using tissue-specific promoters to drive the expression of Cre recombinase, cKO studies have shown that RNA silencing is required for the normal function of diverse cell and tissue types, including T cells (17,18), B cells (19), chondrocytes (20), skin and hair follicles (21,22), brain (23,24), heart (25,26), skeletal muscle (27), lung epithelium (28), pancreatic islets (29), limb mesoderm (30), and retina (31). With regard to reproduction, Dicer is required for normal fertility. In male mice, Dicer1-deficient primordial germ cells and spermatogonia show a reduction in proliferation, resulting in a block in spermatogenesis and infertility after 8 months of age (32). In females, conditional deletion of Dicer1 has so far only been reported in germ cells. cKO of Dicer1 in mouse oocytes results in sterility due to meiotic defects secondary to disorganized spindle formation (33,34). More recently, characterization of mice homozygous for a hypomorphic allelic of Dicer1 has suggested that Dicer is involved in corpus luteum angiogenesis, leading to fertility defects (35). From this hypomorph model, however, it is unclear whether the observed phenotype arises secondary to deficiency of Dicer in endothelial cells or whether luteal cell function is directly compromised. Given the fact that 1) steroid hormone receptors are essential for female reproduction, are expressed in multiple tissues of the reproductive tract, and have been shown to be regulated by miRNAs in human cell lines (10); and 2) granulosa cells actively proliferate during folliculogenesis, and cell division is also regulated by miRNAs, we hypothesized that depletion of Dicer in the somatic cells of the female reproductive tract would result in reproductive defects. To this end, we examined the consequences of deletion of Dicer using a cKO approach directed by a knockin of the Cre recombinase gene into the anti-Müllerian hormone receptor type 2 (Amhr2) locus. Cre-mediated recombination in Amhr2cre/+ mice has been observed in the developing Müllerian ducts, ovarian granulosa cells, oviducts, uterus, and somatic cells of the testis (36,37). Dicer1 cKO female mice are sterile and demonstrate decreased ovulation rates, compromised oocyte and embryo integrity, and defects in the oviducts and uterus, therefore revealing novel and essential roles for Dicer-dependent pathways in the development and function of the female reproductive tract. RESULTS Dicer1 cKO Female Mice Are Sterile To study the functions of Dicer in the female reproductive tract, we generated a cKO mouse model using Cre-mediated recombination under the control of the Amhr2 promoter. Absence of Amhr2 or its ligand, anti-Müllerian hormone, results in persistent Müllerian duct syndrome in males and leads to fertility defects mainly in male mice (38,39). Amhr2-Cre is expressed embryonically in the mesenchyme of the developing Müllerian ducts and postnatally in ovarian granulosa cells and the smooth muscle and stromal cells of the oviducts and uterus (36,37,40,41). Temporal expression of Amhr2-Cre in the Müllerian duct mesenchyme has been previously characterized using two mouse reporter lines, ROSA (36) and EGFP (40). Results from these studies are conflicting; when ROSA reporter mice were used, expression was detected at E12.5 (36), whereas when an EGFP reporter line was used, expression was detected at E15.5, and it was not detected in all mesenchymal cells (40). Amhr2-Cre transgenic mice have been used to characterize the anti-Müllerian hormone signaling cascade in the mesenchyme surrounding the developing Müllerian ducts (36), TGFβ superfamily signaling in postnatal ovarian granulosa cells (42,43,44,45), and depletion of the orphan nuclear receptor, chicken ovalbumin upstream promoter transcription factor II (COUP-TFII), in the stromal cells and smooth muscle layers of the postnatal uterus (46). We crossed Dicer1+/− Amhr2cre/+ mice to Dicer1flox/flox mice to generate Dicer1flox/− Amhr2cre/+ experimental mice (designated throughout as Dicer1 cKO), Dicer1flox/− mice (designated as control), and Dicer1flox/+ mice (designated as wild type). Dicer1 cKO mice were born at the expected Mendelian frequency and appeared healthy. Tissue-specific recombination of the Dicer1 floxed allele was assessed by Western blot analysis in oviducts and uterus from wild-type, control, and Dicer1 cKO mice (Fig. 1 1).
To test the fertility of Dicer1 cKO and control females, we mated 10 females of each genotype to wild-type males beginning at 6 wk of age. Whereas control females had normal fecundity and fertility (9.2 ± 0.4 pups per litter; 1.2 ± 0.04 litters/month; see Table 1), Dicer1 cKO females were sterile over the same 13- to 30-wk period. These findings indicate that Dicer-dependent pathways in the female reproductive tract are necessary for fertility.
Paratubal Cysts Are Prominent in Dicer1 cKO Mice Because Amhr2 drives expression of Cre in multiple tissues of the female reproductive tract, several potential etiologies could be responsible for the sterility in Dicer1 cKO females, including aberrant mating behavior, defects in ovarian folliculogenesis or ovulation, poor fertilization, compromised oocyte/embryo integrity, oviductal defects, or an impaired uterine decidual response. To gain insight into these possibilities, we examined the reproductive tracts of Dicer1 cKO females at various time points postnatally. In 12-wk-old mutants, we observed bilateral paratubal cysts that contained clear, colorless fluid (Fig. 2 2,
To determine the structural relationship between the oviduct and the paratubal cysts in adult Dicer1 cKO mice, we injected dye into the uterine lumen near the uterotubal junction and examined its dispersal in the oviducts. The dye highlighted the tortuous path of the oviducts and also entered the cysts (Fig. 2N 2N), Histological analysis of oviducts from control females at all ages demonstrated relatively uniform periodic acid Schiff (PAS)-positive columnar epithelium throughout most of the structure (Fig. 3 3,
Because paratubal cysts were present in 3-wk-old cKO females and grew larger as the mice aged, we hypothesized that reproductive hormones might influence such growth. However, treatment with pregnant mare serum gonadotropin (PMSG) followed by human chorionic gonadotropin (hCG), a LH analog, did not influence the size of the cysts. Furthermore, treatment of 3-wk-old mice with 17β-estradiol for 3 d had no significant effect on the size of the cysts, despite the fact that estrogen receptor α was present in the nuclei of epithelial cells lining the cysts (data not shown). Ovarian Defects Are Limited in Dicer1 cKO Mice Because Amhr2-Cre transgenic mice have also been used to study the postnatal functions of genes expressed in developing follicles (42,43,44,45), we analyzed the consequences of Dicer1 deletion in ovarian granulosa cells. Histological analysis of ovaries from 3-wk-old control and Dicer1 cKO females showed no obvious differences. In addition, ovaries from 6-wk-old and 12-wk-old control and cKO females contained follicles at all stages of folliculogenesis as well as corpora lutea (Fig. 4 4,
Ovulation and Early Embryonic Defects in Dicer1 cKO Females Because the ovaries of prepubertal Dicer1 cKO mice appeared normal, we next investigated the responsiveness of immature Dicer1 cKO and control females to gonadotropins. Three- to 4-wk-old mice were pharmacologically superovulated with PMSG followed by hCG and then mated with stud males of proven fertility to examine ovulation, fertilization, and early embryonic development. Dicer1 cKO females ovulated approximately half the number of oocytes compared with controls, whereas no significant differences in ovulation rates were found between controls and wild-type littermates (Fig. 5A 5A).
Dicer1 cKO Females Have Normal Serum FSH and Estradiol Levels but Abnormal Estrous Cycles The results described above indicate that Dicer1 cKO mice can mate with stud males and generate copulatory plugs when hormones are administered to override the normal hypothalamic-pituitary-gonadal axis. However, because the Dicer1 cKO females display ovarian defects, and the ovary plays a critical role in the regulation of the estrous cycle, we examined serum hormone levels and estrous cycles of adult control and Dicer1 cKO females. No significant differences were found in serum FSH levels of randomly cycling mice at 6 wk (control: 8.8 ± 2.3, n = 12; cKO: 8.0 ± 2.6, n = 9) and 12 wk (control: 3.3 ± 0.9, n = 4; cKO: 3.5 ± 0.5, n = 3). Likewise, serum estradiol levels were similar between control and cKO females at 6 wk (control: 12.1 ± 1.9, n = 12; cKO: 11.0 ± 2.2, n = 9) and 12 wk (control: 12.0 ± 3.2, n = 4; cKO: 13.0 ± 2.9, n = 4). However, by monitoring estrous cycles with daily vaginal smears over a 3-wk period, we observed that Dicer1 cKO females trended toward shorter estrus and longer metestrus phases as compared with control females (Fig. 5D 5D). Oocytes, Spermatozoa, and Embryos Are Trapped in the Paratubal Cysts of Dicer1 cKO Oviducts Because Dicer1 cKO female mice are sterile despite the fact that they ovulate oocytes that can be fertilized to produce embryos, we next addressed whether defects in the oviduct and/or uterus prevented implantation. As mentioned above and illustrated in Fig. 2M 2M, Dicer1 cKO Uteri Are Shorter but Demonstrate Normal Decidualization The uterus consists of two major compartments, the myometrium and the endometrium. The myometrium consists of two smooth muscle layers whereas the endometrial compartment consists of luminal and glandular epithelial cells as well as supporting stromal cells. Because the Amhr2 promoter directs the expression of Cre strongly to the smooth muscle cells of the myometrium and more weakly to the endometrial stromal cells (46), we next investigated the effect of Dicer1 loss in the uterus. At all ages examined, the uterine horns of Dicer1 cKO mice were shorter compared with those of control females and weighed less (Fig. 6C 6C).
To determine the functional response of Dicer1 cKO uteri to endocrine stimulation, mice were injected with PMSG followed by hCG to induce an increase in ovarian steroid hormone production. The mice were then killed 20 h later, and uterine weights were recorded and normalized to body weights. Because Dicer1 cKO uteri are smaller than those of controls, we also recorded uterine weights from unstimulated mice to evaluate the relative response to hormonal stimulation. Uteri from unstimulated and PMSG/hCG-treated Dicer1 cKO mice weighed significantly less than wild-type uteri; however, the relative increase in uterine weight after hormonal stimulation was comparable between wild-type (2.7-fold) and cKO (3.6-fold) females (Fig. 6C 6C). Embryo implantation depends on the uterine response to both estrogen and progesterone, and on the ability of stromal cells to decidualize. Although the estradiol response of Dicer1 cKO females appeared to be normal, progesterone responsiveness and stromal cell differentiation might be affected by loss of Dicer. Due to the ovulatory defect in Dicer1 cKO females, we chose to evaluate decidualization by inducing an artificial decidual reaction as previously described (47). Ten days after ovariectomy, control and Dicer1 cKO mice were subjected to a steroid hormone regimen (see Materials and Methods), and one uterine horn was given a decidual stimulus (injected with oil) while the contralateral horn served as an unstimulated control. The mice were then treated with estrogen and progesterone daily and killed on the fifth day after trauma. As shown in Fig. 6 6, Conditional Deletion of Dicer1 in the Oviduct Leads to Specific Changes in miRNA Levels Because Dicer processes miRNA precursors into mature miRNAs, we hypothesized that conditional deletion of Dicer1 would cause a global reduction in the levels of miRNAs in the affected tissues. To test this hypothesis, we performed Illumina/Solexa deep sequencing of small RNAs in oviducts of 3- to 4-wk-old wild-type and Dicer1 cKO mice, which already have visible paratubal cysts. Oviducts were the tissue of choice because they displayed the most striking phenotype. We generated 4,225,815 and 4,192,829 small RNA sequences for two independent wild-type samples, and 3,828,843 and 4,070,145 small RNA sequences for two independent Dicer1 cKO samples. Unexpectedly, the proportion of small RNA sequences that mapped to known mouse miRNAs was comparable between wild-type (79.3% and 79.6%) and Dicer1 cKO (78.4% and 79.3%) oviducts. Despite these global similarities, we detected 28 miRNAs that were down-regulated in cKO oviducts compared with wild type (Table 2).
To examine the potential functional consequences of these alterations, we used three different algorithms (TargetScan, PicTar, and miRanda) to predict the mRNA targets of these down-regulated miRNAs. Interestingly, 23 of the 28 miRNAs were predicted to target one to four genes known to be involved in Müllerian duct differentiation and mesenchyme-derived structures (Table 2). The Müllerian duct proliferates and differentiates in an anterior to posterior manner to form the oviduct, uterus, cervix, and upper part of the vagina in a process that is completed by postnatal day 15 (48). Müllerian duct differentiation and maturation involves members of the wingless family of secreted glycoproteins (Wnt4, Wnt5a, Wnt7a) and the homeobox transcription factors (Hoxa9, Hoxa10, Hoxa11, Hoxa13) (49,50). Hoxa9, Hoxa10, Hoxa11, and Hoxa13 are expressed along the axis of the Müllerian duct at birth, and their expression persists in the adult reproductive tract where they are proposed to define functional and tissue identities (51). Our analysis predicted Wnt4 and Wnt5a as targets for three and six miRNAs, respectively (Table 2). Similarly, all Hoxa genes mentioned above are predicted to be targets of one or more miRNAs. In addition, our analysis predicted changes in genes that are important for mesenchyme-derived structures, including smooth muscle differentiation markers such as transgelin (Tagln) and desmin (Des) (52,53,54,55). Conditional Deletion of Dicer1 in the Oviduct Leads to Significant Changes in the Expression of Genes That Are Critical for Müllerian Duct Differentiation and Mesenchyme-Derived Structures As indicated above, our target analysis of miRNAs that were down-regulated in oviducts from Dicer1 cKO mice predicted changes in various genes involved in Müllerian duct differentiation and genes relevant to mesenchyme-derived structures. One mechanism of miRNA function is through cleavage of mRNA targets. Therefore, we examined the expression of candidate target genes by performing quantitative real-time PCR (QPCR) analysis on oviducts from 3- to 4-wk-old wild-type and Dicer1 cKO females (Fig. 7 7
We also observed significant changes in the wingless family member Wnt5a, but not in Wnt4 levels. Embryonically, Wnt7a is expressed throughout the Müllerian duct epithelium, but it becomes restricted to the oviduct and uterine luminal epithelium soon after birth (50,56). Wnt7a plays a pivotal role in Müllerian duct patterning and in the maintenance of Hoxa10 and Hoxa11 gene expression in the uterus (56). Similar to Dicer1 cKO mice, Wnt7a knockout mice display uterine horns that are shorter and thinner than their control counterparts, as well as defects in oviduct coiling (56,57). Interestingly, we observed a significant increase in Wnt7a levels in Dicer1 cKO oviducts. Wnt proteins exert their actions through two signaling pathways, canonical and noncanonical, via interactions with members of the Frizzled (Fzd) family of receptors (58). The canonical pathway involves β-catenin (Ctnnb1) and its downstream targets (58). Fzd1 is expressed in the Müllerian duct mesenchyme and epithelium and has been proposed to mediate β-catenin activation by Wnt proteins in this tissue (40). In contrast to our prediction analysis, Ctnnb1 and Fzd1 were unchanged in Dicer1 cKO oviducts. The mesenchyme of the Müllerian duct gives rise to the smooth muscle of the oviduct and uterus. Dicer1 cKO oviducts showed a significant increase in the smooth muscle markers transgelin (Tagln) and desmin (Des) (52,53,54,55), but not in other smooth muscle markers such as smooth muscle actin (Acta2) (59), the actin-linked regulatory protein calponin 1 (Cnn1) (60), myosin heavy chain 11 (Myh11) (59), and the cytoskeletal protein smoothelin (Smtn) (61). In addition, no significant changes were observed in MAPK 7 (Mapk7), which is required for vascular smooth muscle cell migration (62,63). Vimentin (Vim), the predominant filament in mesenchymal cells, was significantly up-regulated in Dicer1 cKO oviducts. Caldesmon 1 (Cald1), a protein that is present in both smooth muscle and epithelial cells of chicken and bovine oviducts (64,65), and that interacts with actin, myosin, tropomyosin, and calmodulin (60), was also significantly up-regulated in Dicer1 mutant oviducts. No significant changes were observed in forkhead box J1 (Foxj1), a marker for ciliated epithelial cells of the oviduct (66), or in oviductal glycoprotein 1 (Ovgp1), a marker for secretory epithelial cells of the oviduct (67,68). DISCUSSION Consistent with the important roles played by regulatory RNAs in mammalian development and postnatal physiology, deletion of Dicer1, the gene encoding the key enzyme involved in miRNA and siRNA biogenesis, in the female reproductive tract leads to multiple defects. In this study, we show that loss of Dicer1 in somatic cells of the ovary, oviduct, and uterus causes infertility due to defects in ovarian function and the presence of paratubal cysts. Our experiments demonstrate that ovaries from Dicer1 cKO females are without obvious defects at 3 wk of age, although superovulation of immature females yielded half the expected number of oocytes, suggesting an abnormal response to gonadotropin stimulation or defects in ovulation. Because the response to PMSG appears to be normal, at least in terms of granulosa cell proliferation, the decrease in ovulation rates might be attributed to altered LH responsiveness. Dicer1 cKO females also have abnormal estrous cycles, with shorter estrus and longer metestrous phases. In addition, histological analysis of adult ovaries showed increased follicle loss, which has been previously associated with alterations in estrous cycle length (69). Experiments in which unstimulated adult female mice were mated to males of known fertility showed absence of blastocysts in the uteri of Dicer1 cKO females at 3.5 d after coitus, whereas control females showed normal blastocyst recovery. However, we were able to retrieve blastocysts, developmentally arrested embryos, and numerous zona pellucida remnants from the paratubal cysts of Dicer1 cKO females. These results suggest that although ovulation and fertilization occur in Dicer1 cKO females, fewer embryos reach the blastocyst stage, and all unfertilized oocytes and embryos become trapped in the oviductal cysts. Infertility caused by embryo entrapment in the oviduct has been previously reported to occur in cannabinoid receptor 1 null mice, which show defects in oviduct contraction, although in the absence of cysts (70). Therefore, both the physical and functional integrity of the oviduct is essential for normal reproduction. Although we cannot rule out the idea that the oviductal environment may adversely affect embryonic development, the decreased ability of embryos from superovulated immature females to progress to the two-cell stage in vitro suggests that the quality of oocytes from Dicer1 cKO females is compromised. Because Dicer was deleted in the somatic cell compartment of the ovary, the observed defects in oocyte quality are likely due to altered communication between oocytes and granulosa cells (71). In this context, regulatory RNAs have been shown to be essential for follicular function in fruit flies, because combined loss of Dicer and its interacting protein R2D2, which is expressed in the somatic cells of the ovary, causes defective oogenesis (72). To our knowledge, this is the first mouse model of paratubal cysts. These cysts were present in Dicer1 cKO females as early as postnatal day 16 and became larger with age, which suggested the possibility of hormonal regulation; however, we were unable to induce cyst growth in immature females by stimulation with either gonadotropins or estrogen. Despite this, we cannot discard the possibility that progesterone may have an impact on cyst growth. In addition, the presence of a large number of zona pellucida remnants in the cysts is intriguing, given the fact that the response of Dicer1 cKO females to gonadotropins is reduced compared with that of control mice, and the Dicer1 cKO estrous cycles are abnormal. A likely explanation is that the remnants are products of repeated estrous cycles in which oocytes became trapped in the cysts, with the zona pellucidae remaining long after oocyte degeneration. Decreased levels of selected miRNAs have been demonstrated in other Dicer1 cKO mouse models (17,18,19,21,22,23,24,27,30,31) and in Dicer-deficient embryonic stem cells (14); however, global decreases in miRNA levels have rarely been reported in somatic cells of other Dicer1 cKO mouse models (20,26), although they have been shown to occur in Dicer1 cKO oocytes (34) and Dicer null embryonic stem cells (16). Our high-throughput sequencing of small RNAs showed comparable proportions of miRNA sequences in oviducts from 3- to 4-wk-old wild-type and Dicer1 cKO mice, which already have visible paratubal cysts. Further analysis showed that 28 miRNAs were down-regulated in Dicer1 cKO oviducts. Dicer is decreased only in mesenchyme-derived structures of the oviduct and uterus (i.e. smooth muscle and stromal cells), but not in the epithelium. Therefore, it is possible that normal levels of Dicer in the oviduct epithelium may mask a more dramatic decrease in miRNA levels. The fact that previous studies showed that not all mesenchymal cells in the Müllerian duct undergo recombination in the Amhr2-Cre mouse line (40) may also contribute. Additionally, because the spatiotemporal expression of miRNAs in the prenatal Müllerian duct and postnatal oviduct is unknown, it is possible that our findings accurately reflect the loss of miRNAs that are relevant to mesenchyme-derived structures of the oviduct after postnatal differentiation is completed. Importantly, several genes involved in Müllerian duct differentiation were predicted to be targets of one or more miRNAs that were differentially expressed in Dicer1 cKO oviducts. Predicted targets included, but were not limited to, Wnt family genes, Hoxa genes, and smooth muscle markers. Abnormal expression of several of the putative targets was confirmed by QPCR analysis, whereas the levels of others were unchanged. For instance, Wnt4, Fzd1, Ctnnb1, and Cnn1 were predicted to be targeted by at least two miRNAs; however, we found no significant changes in their mRNA levels. MiRNA regulation of these genes may occur through translational repression instead of mRNA cleavage, in which case only protein levels would be altered. Hoxa genes are expressed on the longitudinal axis of the Müllerian duct during embryogenesis, and their spatial distribution and expression persist in the adult reproductive tract. As predicted, our results show up-regulation of Hoxa9, which is normally expressed in the oviduct (51), and Hoxa10, which is important for development of the uterotubal junction and is expressed in the uterus (49,73). Similarly, Wnt5a, which is predominantly expressed in the uterine stroma and epithelium, was also up-regulated. The increase in Hoxa gene expression could be attributed to the loss of regulatory miRNAs; however, because none of the miRNAs that were differentially expressed in Dicer1 cKO oviducts have been confirmed to target Hoxa9, Hoxa10, or Wnt5a, we cannot rule out the possibility that abnormal expression of other factors may contribute to the observed increase. For example, Wnt7a, which was up-regulated in Dicer1 cKO oviducts, has been shown to activate and sustain expression of Hoxa10, possibly via regulation of Wnt5a (50). It is likely that the increase in Wnt7a mRNA is an indirect effect of Dicer1 deletion in the oviduct mesenchyme, because postnatal expression of Wnt7a is limited to the luminal epithelium of the uterus (50). This hypothesis is supported by studies showing that the molecular cues from the mesenchyme induce differentiation of the Müllerian duct epithelium 4–5 d after birth (74). We also found increased expression of the smooth muscle markers transgelin (Tagln) and desmin (Des), the intermediate filament vimentin (Vim), and caldesmon 1 (Cald1). The impact of such changes on the physiology of the oviduct and their contribution to the Dicer1 cKO phenotype remain to be elucidated. Other models have been created to study the function of Dicer1 in the female reproductive tract. Whereas our studies were focused on the deletion of Dicer1 in the somatic cells surrounding the oocytes, as well as in the oviduct and uterus, two other groups demonstrated that loss of Dicer1 specifically in oocytes resulted in arrest at meiosis I and sterility (33,34). Likewise, studies in a hypomorphic Dicer1 mouse model showed that the vascular compartment of the corpus luteum was compromised, thereby affecting progesterone circulation and female reproduction (35). Surprisingly, this latter model did not show ovulation defects, embryo abnormalities, oviductal cysts, or altered uterine size, indicating that low levels of Dicer1 outside of the vasculature are sufficient to generate viable gametes and that only through ablation in specific cells can the roles of Dicer be observed. Apart from decreased uterine size, Dicer1 cKO females do not show any defects in uterine function, as they respond to estrogen and decidual stimuli similar to controls. Because Amhr2-Cre does not ablate gene expression in the uterine epithelial cell compartment, and it is only weakly active in the uterine stroma, these results were expected. Recently, ablation of an endometrial stroma-expressed gene, chicken ovalbumin upstream promoter transcription factor II (COUP-TFII), showed two different phenotypes when conditionally ablated using Amhr2-Cre (46) or progesterone receptor (PR)-Cre transgenic mice (75). This was attributed to differences in the compartmental expression and relative efficiencies of Cre recombination (46). Because the PR-Cre mouse line efficiently ablates gene expression in all compartments of the uterus (76), it may be more suited to evaluate the role of Dicer in this tissue. Experiments are underway to understand how Dicer1 conditional deletion in epithelial cells of the uterus affects implantation and to define the changes in miRNAs/siRNAs that may be responsible for those effects. MATERIALS AND METHODS Generation and Genotyping of Dicer1 cKO Mice The Dicer1 conditional allele (designated throughout as Dicer1flox) and Dicer1 null allele (designated throughout as Dicer1−) have been described (22) and were maintained on a C57BL/6J;129S5/SvEvBrd mixed hybrid background. Mice were genotyped from tail genomic DNA using PCR primers as described (32). Dicer1+/− mice were bred to Amhr2cre/+ mice (36) to generate Dicer1+/− Amhr2cre/+ mice, which were then bred to Dicer1flox/flox mice to generate Dicer1flox/− Amhr2cre/+ experimental mice (designated throughout as Dicer1 cKO), Dicer1flox/− mice (designated as control), and Dicer1flox/+ mice (designated as wild type). All mice were maintained in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Western Blot Analysis Protein lysates from oviducts and uteri of 3- to 4-wk-old wild-type (Dicer1flox/+), control (Dicer1flox/−), and Dicer1 cKO (Dicer1flox/− Amhr2cre/+) female mice were electrophoresed through a NuPAGE 3–8% Tris-Acetate gel (Invitrogen, Carlsbad, CA) and then transferred to a nitrocellulose membrane. Immunoblotting was performed using a rabbit polyclonal antibody against Dicer1 at a 1:1000 dilution [ab1416, a kind gift from David Livingston (14)]. Blots were stripped and reprobed using a mouse monoclonal antibody against β-actin at a 1:10,000 dilution (Sigma A5441; Sigma Chemical Co., St. Louis, MO) to verify equal loading of samples. Bands were visualized using the SuperSignal West Pico Chemiluminescent Substrate Kit (Pierce Biotechnology, Rockford, IL). A total of three independent samples per genotype were analyzed in three independent experiments. Fertility Analysis To evaluate reproductive performance, 10 individually housed 6-wk-old Dicer1 cKO and Dicer1flox/− females were bred to wild-type C57BL/6J;129S5/SvEvBrd hybrid males with known fertility. The numbers of litters and pups were recorded over a 13- to 30-wk period. Tissue Collection and Histological Analysis Ovaries, oviducts, and uteri were dissected and fixed in 10% neutral buffered formalin for histology, snap frozen for protein or RNA isolation, or preserved in RNAlater (Applied Biosystems, ABI, Foster City, CA). Tissue processing and embedding were performed by the Department of Pathology Core Services laboratory (Baylor College of Medicine, Houston, TX). Histological sections were cut at 5 μm and stained with periodic acid-Schiff/hematoxylin or hematoxylin-eosin using standard techniques. Oviductal Dye Injection The oviducts and paratubal cysts of adult Dicer1 cKO females were dissected in M2 medium (Sigma) and dye (0.25% bromophenol blue, 0.25% xylene cyanol, and 15% Ficoll type 400 in deionized water) was injected into the uterine lumen near the uterotubal junction using a 30-gauge needle. TUNEL Staining Analysis of apoptosis in 6-wk-old ovaries was carried out by TUNEL assay using the ApopTag Plus Fluorescein In Situ Apoptosis Detection Kit (Chemicon International, Temecula, CA). Ovaries were fixed in 10% neutral buffered formalin, embedded, and sectioned at 5 μm. Three sections from each of three independent control and Dicer1 cKO ovaries were analyzed in parallel. TUNEL assay was performed according to the manufacturer’s instructions, and slides were mounted in Vectashield (Vector Laboratories, Inc., Burlingame, CA) containing propidium iodine to visualize chromatin. Slides were analyzed by confocal microscopy. The total number of TUNEL-positive follicles per section were counted and normalized to the total number of follicles. Data are presented as the average percent of TUNEL-positive follicles per section ± sem. Superovulation and Isolation of Oocytes/Embryos Superovulation experiments were carried out as described (77). Twenty-two to 25-d-old Dicer1flox/+, Dicer1flox/−, and Dicer1 cKO female mice were injected ip with 5 IU PMSG (Calbiochem, San Diego, CA) for 46 h, followed by ip injection with 5 IU Novarel (Ferring Pharmaceuticals, Parsippany, NJ). Mice were then bred to wild-type males with known fertility. Eggs and/or embryos were recovered from the ampulla of the oviduct 20 h after Novarel, collected in M2 medium (Sigma) containing 1 mg/ml hyaluronidase (Sigma) to dissociate cumulus cells, counted, and cultured overnight in M16 medium (Sigma). The numbers of one-cell, two-cell, four-cell, and fragmented oocytes/embryos were recorded. Serum Analysis Mice were anesthetized by isoflurane inhalation (Abbott Laboratories, North Chicago, IL), and blood was collected in Microtainer tubes (Becton Dickinson, Franklin Lakes, NJ) by closed cardiac puncture. Serum was separated by centrifugation and stored at −20 C until further use. FSH and estradiol measurements were performed by the University of Virginia Ligand Assay and Analysis Core (Specialized Cooperative Centers Program in Reproduction Research). Assay information is available at http://www.healthsystem.virginia.edu/internet/ crr/ligand.cfm. Monitoring of Estrous Cycles Over a 3-wk period, vaginal smears from 6- to 7-wk-old control and Dicer1 cKO female mice were collected each day between 1300 h and 1400 h. The smears were classified into one of four phases of the estrous cycle (proestrus, estrus, metestrus, diestrus) as described elsewhere (78). Data are presented as the average number of days spent in each phase of the estrous cycle ± sem. Uterine Hormonal Stimulation Three to 4-wk-old Dicer1flox/+, Dicer1flox/−, and Dicer1 cKO female mice were unstimulated or treated with one of the following regimens: 1) 5 IU PMSG ip for 46 h, followed by 5 IU Novarel ip for 20 h; 2) 2 μg 17β-estradiol in 100 μl sesame oil sc, once per day for 3 d (79); or 3) 100 μl sesame oil (vehicle only) sc, once per day for 3 d. Body weights and uterine weights were measured upon cervical dislocation, and the average uterine weight/body weight ± sem was calculated for each group. For each genotype, fold changes between the PMSG/hCG and unstimulated groups were calculated, and fold changes between the 17β-estradiol and vehicle-only groups were calculated. Induction of Decidualization The artificial decidual response has been previously described (47). Briefly, ovariectomized mice were treated with sc injections of 100 ng 17β-estradiol per mouse, once per day for 3 d. After 2 d rest, mice were then treated with sc injections of 1 mg progesterone and 6.7 ng 17β-estradiol per mouse, once per day for 3 d. One uterine horn was traumatized by an intraluminal injection of 50 μl of sesame oil 6 h after the third progesterone and 17β-estradiol injection. The contralateral horn was not traumatized and served as a control. Mice were then given sc injections of 1 mg progesterone and 6.7 ng 17β-estradiol per mouse, once per day. Mice were killed 5 d after the trauma by cervical dislocation while under anesthesia, Avertin (2,2-tribromoethyl alcohol; Sigma). At the time of dissection, uterine tissues were placed in 4% paraformaldehyde. Deep Sequencing of Oviductal Small RNAs Oviducts from 3- to 4-wk-old Dicer1flox/+ and Dicer1 cKO female mice were dissected, pooled by genotype (n = 2 pools per genotype; three to five mice per pool), and preserved in RNAlater (ABI). Total RNA was extracted using the mirVana miRNA Isolation Kit (ABI) and small RNA library construction was performed using the DGE-Small RNA Sample Prep Kit (Illumina, San Diego, CA) according to the manufacturer’s protocol. Purified cDNA was quantified using the Quant-iT PicoGreen dsDNA Kit (Invitrogen) and diluted to 10 nm for sequencing on the Illumina 1G Genome Analyzer at the University of Houston. All unique sequence reads with a minimum read count of 10 were aligned to mouse miRNA sequences in the miRNA database [miRBase version 11.0 (80)] as described elsewhere (81). For each sample, counts were normalized to the total number of small RNA sequences, and then for each miRNA, the average number of counts was compared between genotypes. miRNAs with fold change more than 1.2 and Dicer1flox/+ read count greater than 500 were considered to be differentially expressed. Prediction of Putative miRNA:mRNA Functional Interactions Three established miRNA target prediction algorithms, TargetScan [version 4.1 (82)], PicTar (83), and miRanda [January 2008 (84)], were used to identify potential mRNA targets for miRNAs that were differentially expressed between Dicer1flox/+ and Dicer1 cKO oviducts. Predictions were compiled from Microsoft Excel annotation worksheets consisting of all putative miRNA:mRNA interactions for each algorithm. Annotation worksheets are available at http://sigterms. sourceforge.net. QPCR Oviducts from 3- to 4-wk-old Dicer1flox/+ and Dicer1 cKO female mice were dissected, pooled by genotype (n = 3 pools per genotype; three to five mice per pool), and flash frozen. Total RNA was extracted using the RNeasy Mini Kit (QIAGEN, Valencia, CA) with on-column deoxyribonuclease digestion using the RNase-Free DNase Set (QIAGEN), all according to the manufacturer’s protocol. Total RNA (500 ng) was reverse transcribed in a 50-μl reaction using 250 U Superscript III reverse transcriptase (Invitrogen) and oligo(dT)12–18 primer (Invitrogen). Samples were diluted 50-fold, and 5 μl was used for each QPCR reaction. QPCR was performed on the ABI Prism 7500 Sequence Detection System using predesigned TaqMan Gene Expression Assays (ABI) or custom primers designed using Primer Express software (ABI), and mouse Gapdh as an endogenous control. The following TaqMan assays were used: Wnt4, Mm00437341_m1; Wnt5a, Mm00437347_m1; Wnt7a, Mm00437355_m1; Hoxa10, Mm00433966_m1; Hoxa13, Mm00433967_m1; Ctnnb1, Mm00483033_m1; Vim, Mm00449201_m1; and Gapdh, 4352339E. Custom primers were designed for the following genes and primer sequences are listed in Table 4: Acta2; Cald1; Cnn1; Des; Foxj1; Fzd1; Gapdh; Hoxa9; Mapk7; Myh11; Ovgp1; Smtn; and Tagln. TaqMan PCR was performed using TaqMan Universal PCR Master Mix (ABI), and PCR with custom primers was performed using SYBR Green PCR Master Mix (ABI) in 20 μl. The reaction conditions were as follows: 2 min at 50 C, 10 min at 95 C, followed by 40 cycles of 15 sec at 95 C (denaturation) and 1 min at 60 C (annealing/extension). Each sample was analyzed in duplicate or triplicate and a nontemplate control (nuclease-free water) sample was included on each plate for each primer-probe set. The relative quantity (RQ) of transcript was calculated using the 2-ΔΔCT method (85) and plotted as mean ± sem.
Statistical Analysis Data are presented as the mean ± sem. Statistical analysis was carried out using the JMP version 7.0.1 statistical package (SAS Software, Cary, NC). Statistical differences were tested using Student’s t test or one-way ANOVA followed by Tukey’s honestly significant differences test. P < 0.05 was considered statistically significant. Acknowledgments We thank Alexander Tarakhovsky for Dicer1flox/flox mice, Richard Behringer for Amhr2-Cre mice, David Livingston for Dicer1 antibodies, Chad Creighton for providing annotation worksheets for miRNA target prediction, and the University of Virginia Ligand Assay and Analysis Core (Specialized Cooperative Centers Program in Reproduction Research, Charlottesville, VA) for performing serum hormone assays. We thank the Cullen Foundation for their generous support of the University of Houston’s Institute for Molecular Design, and Zhenkang Xu and Karon Cassidy for sequencing. We also thank Mark Edson for help with uterine studies, Roopa Nalam for help with figures, and Angshumoy Roy and James Orengo for insightful discussions. Footnotes This work was supported by National Institutes of Health Grant CA60651 (to M.M.M.), the Specialized Cooperative Centers Program in Reproduction and Infertility (to F.J.D. and M.M.M.), a Program Project Development Grant from the Ovarian Cancer Research Fund (to P.H.G. and M.M.M.), T32GM008307 (to A.K.N.), the Joseph and Matilda Melnick Endowed Fund (to A.K.N.), and scholarships from Baylor Research Advocates for Student Scientists (to A.K.N. and H.L.F.). The University of Virginia Ligand Assay and Analysis Core (Specialized Cooperative Centers Program in Reproduction Research) was supported by Grant U54 HD28934 from National Institutes of Child Health and Human Development/National Institutes of Health. Disclosure Statement: The authors have nothing to disclose. First Published Online August 7, 2008 Abbreviations: cKO, Conditional knockout; E7.5, embryonic d 7.5; hCG, human chorionic gonadotropin; miRNA, microRNA; PAS, periodic acid Schiff; PMSG, pregnant mare serum gonadotropin; QPCR, quantitative real-time PCR; RNase, ribonuclease; TUNEL, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||
Development. 2005 Nov; 132(21):4645-52.
[Development. 2005]Nat Rev Genet. 2004 May; 5(5):396-400.
[Nat Rev Genet. 2004]EMBO J. 2008 Feb 6; 27(3):471-81.
[EMBO J. 2008]Mol Cell. 2008 Jan 18; 29(1):1-7.
[Mol Cell. 2008]Genes Dev. 2002 Jul 1; 16(13):1616-26.
[Genes Dev. 2002]Nature. 2000 Feb 24; 403(6772):901-6.
[Nature. 2000]Genome Biol. 2003; 4(9):228.
[Genome Biol. 2003]Nat Genet. 2003 Nov; 35(3):217-8.
[Nat Genet. 2003]Nat Genet. 2003 Nov; 35(3):215-7.
[Nat Genet. 2003]Nat Genet. 2003 Nov; 35(3):215-7.
[Nat Genet. 2003]J Biol Chem. 2005 Mar 11; 280(10):9330-5.
[J Biol Chem. 2005]Genes Dev. 2005 Feb 15; 19(4):489-501.
[Genes Dev. 2005]Nat Genet. 2007 Mar; 39(3):380-5.
[Nat Genet. 2007]Proc Natl Acad Sci U S A. 2007 Nov 13; 104(46):18097-102.
[Proc Natl Acad Sci U S A. 2007]PLoS One. 2008 Mar 5; 3(3):e1738.
[PLoS One. 2008]Genes Dev. 2007 Mar 15; 21(6):682-93.
[Genes Dev. 2007]Genes Dev. 2007 Mar 15; 21(6):644-8.
[Genes Dev. 2007]J Clin Invest. 2008 May; 118(5):1944-54.
[J Clin Invest. 2008]Mol Endocrinol. 2007 May; 21(5):1132-47.
[Mol Endocrinol. 2007]Nat Genet. 2002 Nov; 32(3):408-10.
[Nat Genet. 2002]Mol Endocrinol. 2004 Jul; 18(7):1610-9.
[Mol Endocrinol. 2004]Cell. 1994 Nov 4; 79(3):415-25.
[Cell. 1994]Genes Dev. 1996 Oct 15; 10(20):2577-87.
[Genes Dev. 1996]Nat Genet. 2002 Nov; 32(3):408-10.
[Nat Genet. 2002]Mol Endocrinol. 2004 Jul; 18(7):1610-9.
[Mol Endocrinol. 2004]Dev Biol. 2007 Jul 15; 307(2):227-36.
[Dev Biol. 2007]Mol Cell Biol. 2008 Jan; 28(1):248-57.
[Mol Cell Biol. 2008]Mol Endocrinol. 2004 Apr; 18(4):953-67.
[Mol Endocrinol. 2004]Mol Endocrinol. 2006 Jun; 20(6):1406-22.
[Mol Endocrinol. 2006]Mol Endocrinol. 2007 Oct; 21(10):2458-71.
[Mol Endocrinol. 2007]Proc Natl Acad Sci U S A. 2007 Apr 10; 104(15):6293-8.
[Proc Natl Acad Sci U S A. 2007]Biol Reprod. 1972 Aug; 7(1):82-6.
[Biol Reprod. 1972]J Biochem. 2005 Jun; 137(6):677-83.
[J Biochem. 2005]Nat Rev Genet. 2003 Dec; 4(12):969-80.
[Nat Rev Genet. 2003]J Exp Zool. 2001 Nov 1; 290(6):616-23.
[J Exp Zool. 2001]Biol Reprod. 1997 Dec; 57(6):1338-45.
[Biol Reprod. 1997]J Biol Chem. 1995 Jun 2; 270(22):13460-9.
[J Biol Chem. 1995]J Exp Zool. 2001 Nov 1; 290(6):616-23.
[J Exp Zool. 2001]Development. 1998 Aug; 125(16):3201-11.
[Development. 1998]Nature. 1998 Oct 15; 395(6703):707-10.
[Nature. 1998]Genome Biol. 2002; 3(1):REVIEWS3001.
[Genome Biol. 2002]Dev Biol. 2007 Jul 15; 307(2):227-36.
[Dev Biol. 2007]J Biol Chem. 1995 Jun 2; 270(22):13460-9.
[J Biol Chem. 1995]J Cell Biol. 1996 Mar; 132(5):849-59.
[J Cell Biol. 1996]Biochem J. 1987 Jun 15; 244(3):705-9.
[Biochem J. 1987]Differentiation. 1979; 15(1):7-25.
[Differentiation. 1979]Annu Rev Genomics Hum Genet. 2008; 9():283-302.
[Annu Rev Genomics Hum Genet. 2008]Biol Reprod. 2004 Jul; 71(1):130-8.
[Biol Reprod. 2004]Nat Med. 2004 Oct; 10(10):1074-80.
[Nat Med. 2004]Science. 2002 Jun 21; 296(5576):2178-80.
[Science. 2002]Mech Dev. 2008 May-Jun; 125(5-6):475-85.
[Mech Dev. 2008]J Exp Med. 2005 May 2; 201(9):1367-73.
[J Exp Med. 2005]J Exp Med. 2005 Jul 18; 202(2):261-9.
[J Exp Med. 2005]Cell. 2008 Mar 7; 132(5):860-74.
[Cell. 2008]Curr Biol. 2006 May 23; 16(10):1041-9.
[Curr Biol. 2006]Nat Genet. 2006 Mar; 38(3):356-62.
[Nat Genet. 2006]Biol Reprod. 1997 Dec; 57(6):1338-45.
[Biol Reprod. 1997]Nat Rev Genet. 2003 Dec; 4(12):969-80.
[Nat Rev Genet. 2003]Dev Biol. 2000 Aug 15; 224(2):373-87.
[Dev Biol. 2000]J Exp Zool. 2001 Nov 1; 290(6):616-23.
[J Exp Zool. 2001]Zoolog Sci. 2004 Mar; 21(3):319-26.
[Zoolog Sci. 2004]Genes Dev. 2007 Mar 15; 21(6):682-93.
[Genes Dev. 2007]Genes Dev. 2007 Mar 15; 21(6):644-8.
[Genes Dev. 2007]J Clin Invest. 2008 May; 118(5):1944-54.
[J Clin Invest. 2008]Proc Natl Acad Sci U S A. 2007 Apr 10; 104(15):6293-8.
[Proc Natl Acad Sci U S A. 2007]PLoS Genet. 2007 Jun; 3(6):e102.
[PLoS Genet. 2007]Genesis. 2005 Feb; 41(2):58-66.
[Genesis. 2005]Nat Genet. 2006 Mar; 38(3):356-62.
[Nat Genet. 2006]PLoS One. 2008 Mar 5; 3(3):e1738.
[PLoS One. 2008]Nat Genet. 2002 Nov; 32(3):408-10.
[Nat Genet. 2002]Genes Dev. 2005 Feb 15; 19(4):489-501.
[Genes Dev. 2005]Mol Endocrinol. 2002 Jun; 16(6):1154-67.
[Mol Endocrinol. 2002]Endocrinology. 1999 Dec; 140(12):5789-96.
[Endocrinology. 1999]J Endocrinol. 2000 Apr; 165(1):39-49.
[J Endocrinol. 2000]Biol Reprod. 1972 Aug; 7(1):82-6.
[Biol Reprod. 1972]Nucleic Acids Res. 2006 Jan 1; 34(Database issue):D140-4.
[Nucleic Acids Res. 2006]Genome Res. 2008 Oct; 18(10):1571-81.
[Genome Res. 2008]Cell. 2003 Dec 26; 115(7):787-98.
[Cell. 2003]Nat Genet. 2005 May; 37(5):495-500.
[Nat Genet. 2005]PLoS Biol. 2004 Nov; 2(11):e363.
[PLoS Biol. 2004]Methods. 2001 Dec; 25(4):402-8.
[Methods. 2001]